Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide vs Strontium Ranelate in Postmenopausal Osteoporosis
NCT00239629Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
Phase 4, randomised, open-label trial of teriparatide in postmenopausal osteoporosis (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Mineralization Surface / Bone Surface at 6 months. Started Sep 2005; status: completed.
02
Drugs
teriparatide
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00239629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239629.